Skip to main content
Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
31.17
-0.53 (-1.67%)
At close: Nov 4, 2024, 4:00 PM
32.00
+0.83 (2.66%)
Pre-market: Nov 5, 2024, 5:35 AM EST

Immunocore Holdings Revenue

Immunocore Holdings had revenue of $75.40M in the quarter ending June 30, 2024, with 26.18% growth. This brings the company's revenue in the last twelve months to $280.91M, up 27.95% year-over-year. In the year 2023, Immunocore Holdings had annual revenue of $249.43M with 43.05% growth.

Revenue (ttm)
$280.91M
Revenue Growth
+27.95%
P/S Ratio
5.51
Revenue / Employee
$565,219
Employees
497
Market Cap
1.56B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023249.43M75.07M43.05%
Dec 31, 2022174.36M137.88M377.91%
Dec 31, 202136.48M6.37M21.15%
Dec 31, 202030.11M4.45M17.32%
Dec 31, 201925.67M2.02M8.52%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sep 30, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortrea Holdings 3.01B
Teladoc Health 2.59B
Dynavax Technologies 249.69M
Harrow 154.15M
Ocular Therapeutix 61.10M
Intellia Therapeutics 45.97M
Bicycle Therapeutics 36.90M
NewAmsterdam Pharma Company 7.42M
Revenue Rankings

IMCR News

More News